Trial intelligence / Profile preview

Telmisartan vs Losartan in Primary Hypertension

NCT02269176Phase 3Completed

Sponsor
Boehringer Ingelheim
Start
Jul 2000
Primary completion
Jan 2001
Modality
Small Molecules
01

Overview

A Phase 3 trial of telmisartan in primary hypertension, sponsored by Boehringer Ingelheim. Started Jul 2000; status: completed.

02

Drugs

telmisartan
03

Conditions

primary hypertension

Beyond the preview

Go deeper on NCT02269176.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02269176.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call